Eugene Athan

11.4k total citations
141 papers, 3.4k citations indexed

About

Eugene Athan is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Eugene Athan has authored 141 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Epidemiology, 79 papers in Infectious Diseases and 31 papers in Surgery. Recurrent topics in Eugene Athan's work include Mycobacterium research and diagnosis (36 papers), Tuberculosis Research and Epidemiology (27 papers) and Infective Endocarditis Diagnosis and Management (23 papers). Eugene Athan is often cited by papers focused on Mycobacterium research and diagnosis (36 papers), Tuberculosis Research and Epidemiology (27 papers) and Infective Endocarditis Diagnosis and Management (23 papers). Eugene Athan collaborates with scholars based in Australia, United Kingdom and United States. Eugene Athan's co-authors include D. O’Brien, N. Deborah Friedman, Anthony McDonald, Andrew Hughes, Peter Callan, Andrew Hughes, Aaron Walton, Allen Cheng, Paul D. R. Johnson and Vivian H. Chu and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Eugene Athan

137 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Athan Australia 33 2.0k 1.6k 599 567 515 141 3.4k
Jihad Bishara Israel 33 1.8k 0.9× 1.7k 1.0× 408 0.7× 492 0.9× 313 0.6× 131 3.6k
Albert Pahissa Spain 45 4.2k 2.1× 3.1k 1.9× 780 1.3× 1.2k 2.1× 247 0.5× 140 6.3k
Jesús Fortün Spain 43 3.6k 1.9× 3.3k 2.0× 1.0k 1.7× 484 0.9× 197 0.4× 194 5.5k
Elad Goldberg Israel 32 1.1k 0.6× 1.4k 0.9× 361 0.6× 279 0.5× 128 0.2× 96 3.1k
Eric Van Wijngaerden Belgium 36 2.8k 1.4× 3.0k 1.9× 467 0.8× 300 0.5× 175 0.3× 121 6.7k
D. Rebecca Prevots United States 41 4.4k 2.2× 3.7k 2.3× 557 0.9× 452 0.8× 1.7k 3.2× 124 6.5k
N. Deborah Friedman Australia 28 2.0k 1.0× 1.1k 0.7× 1.3k 2.1× 539 1.0× 342 0.7× 99 4.8k
Silvio Pitlik Israel 36 1.5k 0.8× 2.0k 1.2× 695 1.2× 1.3k 2.3× 316 0.6× 153 4.6k
Willy Peetermans Belgium 44 3.3k 1.7× 2.5k 1.5× 860 1.4× 1.0k 1.8× 123 0.2× 201 6.4k
Ellen Jo Baron United States 32 2.0k 1.0× 1.7k 1.0× 855 1.4× 605 1.1× 237 0.5× 94 5.4k

Countries citing papers authored by Eugene Athan

Since Specialization
Citations

This map shows the geographic impact of Eugene Athan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Athan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Athan more than expected).

Fields of papers citing papers by Eugene Athan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Athan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Athan. The network helps show where Eugene Athan may publish in the future.

Co-authorship network of co-authors of Eugene Athan

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Athan. A scholar is included among the top collaborators of Eugene Athan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Athan. Eugene Athan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muhi, Stephen, Justina H. Hill, Anthony McDonald, et al.. (2025). Management of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: consensus statement. The Medical Journal of Australia. 222(11). 571–578. 1 indexed citations
2.
Blasdell, Kim R., Richard Ploeg, Emma C. Hobbs, et al.. (2024). Experimental infection of ringtail possums (Pseudocheirus peregrinus) with Mycobacterium ulcerans, the agent of Buruli ulcer. Scientific Reports. 14(1). 25352–25352. 1 indexed citations
3.
Manning, Laurens, Alexander Rofé, Eugene Athan, et al.. (2024). Patient-Reported Outcomes Following Periprosthetic Joint Infection of the Hip and Knee. Journal of Bone and Joint Surgery. 106(13). 1197–1204. 5 indexed citations
4.
McNamara, Bridgette, et al.. (2024). Prevalence, risk factors, and outcomes of secondary infections among hospitalized patients with COVID-19 or post–COVID-19 conditions in Victoria, 2020-2023. International Journal of Infectious Diseases. 145. 107078–107078. 5 indexed citations
5.
Liew, Kwee Chin, Heera Rajandas, Yin Peng Lee, et al.. (2023). Insights into the Evolution of P. aeruginosa Antimicrobial Resistance in a Patient Undergoing Intensive Therapy. Antibiotics. 12(3). 483–483. 3 indexed citations
6.
O’Brien, D., Kim R. Blasdell, Stephen Muhi, et al.. (2023). Is BCG vaccination of possums the solution to the Buruli ulcer epidemic in south‐eastern Australia?. The Medical Journal of Australia. 219(11). 520–522. 7 indexed citations
7.
8.
9.
McNamara, Bridgette, et al.. (2023). Demographic Characteristics of Unvaccinated Asymptomatic and Symptomatic SARS-CoV-2 Cases in Barwon South West, Victoria, Australia. Pathogens. 12(12). 1420–1420. 1 indexed citations
10.
Green, Jessica, Amelia J. McGuinness, Michael Berk, et al.. (2023). Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial. Pilot and Feasibility Studies. 9(1). 5–5. 15 indexed citations
11.
Röder, Christine, Bridgette McNamara, D. O’Brien, et al.. (2022). Area‐level social and economic factors and the local incidence of SARS‐CoV‐2 infections in Victoria during 2020. The Medical Journal of Australia. 216(7). 349–356. 16 indexed citations
12.
Hall, Victoria, et al.. (2021). Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports. BMC Infectious Diseases. 21(1). 284–284. 16 indexed citations
13.
Röder, Christine & Eugene Athan. (2020). In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection. Drugs in R&D. 20(3). 209–216. 8 indexed citations
14.
Green, Jessica, Jessica A. Davis, Michael Berk, et al.. (2020). Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes. 12(1). 1854640–1854640. 112 indexed citations
15.
Röder, Christine, et al.. (2019). Cost and Outcomes of Implantable Cardiac Electronic Device Infections in Victoria, Australia. Heart Lung and Circulation. 29(7). e140–e146. 8 indexed citations
16.
Davies, John R., Amy Loughman, Michael Berk, et al.. (2019). FMT for the treatment of diseases other than Clostridium difficile: A systematic review protocol. Bipolar Disorders. 21. 139–139. 1 indexed citations
17.
Wade, Amanda, Christine Röder, M. Davies, et al.. (2018). Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct‐acting antiviral therapy for hepatitis C. Journal of Viral Hepatitis. 25(9). 1089–1098. 25 indexed citations
18.
Bond, Katherine, Gemma Vincent, C.R. Wilks, et al.. (2015). One Health approach to controlling a Q fever outbreak on an Australian goat farm. Epidemiology and Infection. 144(6). 1129–1141. 68 indexed citations
19.
Tung, Matthew, et al.. (2014). Evolving epidemiology of injecting drug use-associated infective endocarditis: A regional centre experience. Drug and Alcohol Review. 34(4). 412–417. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jihad Bishara Breakdown of academic impact, for papers by Albert Pahissa Breakdown of academic impact, for papers by Jesús Fortün Breakdown of academic impact, for papers by Elad Goldberg Breakdown of academic impact, for papers by Eric Van Wijngaerden Breakdown of academic impact, for papers by D. Rebecca Prevots Breakdown of academic impact, for papers by N. Deborah Friedman Breakdown of academic impact, for papers by Silvio Pitlik Breakdown of academic impact, for papers by Willy Peetermans Breakdown of academic impact, for papers by Ellen Jo Baron
Rankless by CCL
2026